ImageneBio Statistics
Total Valuation
ImageneBio has a market cap or net worth of $48.83 million. The enterprise value is -$76.46 million.
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ImageneBio has 12.46 million shares outstanding. The number of shares has increased by 17.63% in one year.
| Current Share Class | 12.46M |
| Shares Outstanding | 12.46M |
| Shares Change (YoY) | +17.63% |
| Shares Change (QoQ) | +5.95% |
| Owned by Insiders (%) | 1.87% |
| Owned by Institutions (%) | 20.80% |
| Float | 4.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.17, with a Debt / Equity ratio of 0.01.
| Current Ratio | 16.17 |
| Quick Ratio | 15.68 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.34% and return on invested capital (ROIC) is -22.95%.
| Return on Equity (ROE) | -32.34% |
| Return on Assets (ROA) | -28.56% |
| Return on Invested Capital (ROIC) | -22.95% |
| Return on Capital Employed (ROCE) | -37.24% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.41M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -230,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.52% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -46.52% |
| 50-Day Moving Average | 4.27 |
| 200-Day Moving Average | 5.39 |
| Relative Strength Index (RSI) | 48.30 |
| Average Volume (20 Days) | 17,883 |
Short Selling Information
The latest short interest is 45,958, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 45,958 |
| Short Previous Month | 61,349 |
| Short % of Shares Out | 0.37% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 3.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -50.08M |
| Pretax Income | -43.56M |
| Net Income | -43.33M |
| EBITDA | -49.39M |
| EBIT | -50.08M |
| Earnings Per Share (EPS) | -$3.29 |
Full Income Statement Balance Sheet
The company has $126.60 million in cash and $1.31 million in debt, with a net cash position of $125.29 million or $10.06 per share.
| Cash & Cash Equivalents | 126.60M |
| Total Debt | 1.31M |
| Net Cash | 125.29M |
| Net Cash Per Share | $10.06 |
| Equity (Book Value) | 128.14M |
| Book Value Per Share | 10.29 |
| Working Capital | 122.52M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -40.61M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 692,250 |
| Net Borrowing | n/a |
| Free Cash Flow | -40.61M |
| FCF Per Share | -$3.26 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ImageneBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.63% |
| Shareholder Yield | -17.63% |
| Earnings Yield | -84.03% |
| FCF Yield | -83.17% |
Analyst Forecast
The average price target for ImageneBio is $18.00, which is 359.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.00 |
| Price Target Difference | 359.18% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ImageneBio has an Altman Z-Score of 0.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.18 |
| Piotroski F-Score | 2 |